Ark Invest analyst Ali Urman compares Covid-19 vaccines from John and Johnson, Pfizer, and Moderna and others. She says Johnson and Johnson said that we will likely see data by the end of January with their earnings call coming up and it may come up there. There is also a 50 percent threshold for the efficacy for the vaccine and Ali is hoping for a 80 to 95 percent efficacy.
Morning Trade Live
25 Jan 2021
Market On Close
10 Nov 2020
Morning Trade Live
09 Nov 2020
Morning Trade Live
07 Dec 2020
Market On Close
01 Dec 2020
The Watch List
15 Jan 2021
Morning Trade Live
25 Feb 2021
Ark Invest analyst Ali Urman compares Covid-19 vaccines from John and Johnson, Pfizer, and Moderna and others. She says Johnson and Johnson said that we will likely see data by the end of January with their earnings call coming up and it may come up there. There is also a 50 percent threshold for the efficacy for the vaccine and Ali is hoping for a 80 to 95 percent efficacy.
Morning Trade Live
25 Jan 2021